<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="5â€²-monophosphate analog called EdAP (5). EdAP exhibited potent inhibition against" exact="influenza" post="virus multiplication in Madinâ€&quot;Darby canine kidney (MDCK) cells transfected"/>
 <result pre="this DNA-type nucleic acid analog (5) inhibited the multiplication of" exact="influenza" post="A virus, although influenza virus is an RNA virus"/>
 <result pre="analog (5) inhibited the multiplication of influenza A virus, although" exact="influenza" post="virus is an RNA virus that does not generate"/>
 <result pre="an RNA virus that does not generate DNA. 4â€²-ethynyl-2â€²-deoxyadenosine 5â€²-monophosphate" exact="influenza" post="anti-influenza activity 1. Introduction Influenza caused by influenza A"/>
 <result pre="4â€²-ethynyl-2â€²-deoxyadenosine 5â€²-monophosphate influenza anti-influenza activity 1. Introduction Influenza caused by" exact="influenza" post="A virus is an infectious respiratory disease, which is"/>
 <result pre="Introduction Influenza caused by influenza A virus is an infectious" exact="respiratory disease," post="which is responsible for seasonal epidemics and periodic global"/>
 <result pre="medicine has been frequently reported to limit treatment efficiency. The" exact="influenza" post="A virus is a negative-sense single-strand RNA virus with"/>
 <result pre="antiviral compound. The inhibitors should work against several subtypes of" exact="influenza" post="A viruses and be tolerated by a drug-resistant mutant"/>
 <result pre="a drug-resistant mutant because it is highly conserved in all" exact="influenza" post="subtypes and is essential to the viral life cycle."/>
 <result pre="5â€²-monophosphate analog called EdAP (5) as a potent inhibitor of" exact="influenza" post="A virus. Interestingly, this DNA-type nucleic acid analog inhibited"/>
 <result pre="Interestingly, this DNA-type nucleic acid analog inhibited the multiplication of" exact="influenza" post="A virus, although influenza A virus is an RNA"/>
 <result pre="acid analog inhibited the multiplication of influenza A virus, although" exact="influenza" post="A virus is an RNA virus that does not"/>
 <result pre="on our hypothesis that EFdA analogs may work against the" exact="influenza" post="virus [25]. The adenosine derivatives of compounds 1â€&quot;3 were"/>
 <result pre="3). Consequently, compound 5 significantly inhibited the growth of the" exact="influenza" post="virus, with an IC50 of 3.8 Î¼M, whereas no"/>
 <result pre="inhibition level of 5 was around a 79% decrease of" exact="influenza" post="virus-produced NPs. This level is comparable to that of"/>
 <result pre="MD. 3.2.2. Virus As described previously [38], the number of" exact="influenza" post="A/Narita/1/09 H1N1pdm viruses were increased in MDCKâ€&quot;SIAT1 cells containing"/>
 <result pre="inhibitor-containing MEM medium on the cells was replaced with the" exact="influenza" post="virus-inhibitor mixture. After incubation at 37 Â°C in a"/>
 <result pre="(4E6) and secondary Î²-galactosidase-conjugated antimouse IgG antibody. The number of" exact="influenza" post="virus-produced nucleoproteins (NPs) in the permeabilized cells in each"/>
 <result pre="only the virus was used to express the number of" exact="influenza" post="virus-produced NPs in each well. Then, a graph was"/>
 <result pre="was generated by plotting the percentage of relative numbers of" exact="influenza" post="virus-produced NPs against the logarithm of the inhibitor concentrations."/>
 <result pre="50% in comparison to the control (IC50) was obtained. The" exact="influenza" post="virus-produced NPs in the permeabilized cells in each well"/>
 <result pre="developed EdAP, a new 4â€²-ethynyl-2â€²-deoxyadenosine 5â€²-monophosphate analog, as a potent" exact="influenza" post="A inhibitor with an IC50 of 3.8 Î¼M. EdAP"/>
 <result pre="References References 1.Global Influenza Strategy 2019â€&quot;2030World Health OrganizationGeneva, Switzerland2019 2.StevaertA.NaesensL.The" exact="influenza" post="virus polymerase complex: An update on its structure, functions,"/>
 <result pre="23.StoddartC.A.GalkinaS.A.JoshiP.KosikovaG.MorenoM.E.RiveraJ.M.SloanB.ReeveA.B.SarafianosS.G.Murphey-CorbM.et al.Oral administration of the nucleoside EFdA (4â€²-ethynyl-2-fluoro-2â€²-deoxyadenosine) provides rapid" exact="suppression" post="of HIV viremia in humanized mice and favorable pharmacokinetic"/>
 <result pre="Chem.2000434516452510.1021/jm000209n11087576 26.SriwilaijaroenN.WilairatP.HiramatsuH.TakahashiT.SuzukiT.ItoM.ItoY.TashiroM.SuzukiY.Mechanisms of the action of povidone-iodine against human and" exact="avian influenza" post="A viruses: Its effects on hemagglutination and sialidase activitiesVirol."/>
 <result pre="26.SriwilaijaroenN.WilairatP.HiramatsuH.TakahashiT.SuzukiT.ItoM.ItoY.TashiroM.SuzukiY.Mechanisms of the action of povidone-iodine against human and avian" exact="influenza" post="A viruses: Its effects on hemagglutination and sialidase activitiesVirol."/>
 <result pre="apricot fruit juice concentrate show multiple inhibitory effects on pandemic" exact="influenza" post="A (H1N1) virusFood Chem.20111271910.1016/j.foodchem.2010.12.031 39.SriwilaijaroenN.MageshS.ImamuraA.AndoH.IshidaH.SakaiM.IshitsuboE.HoriT.MoriyaS.IshikawaT.et al.A novel potent and"/>
 <result pre="Chem.20111271910.1016/j.foodchem.2010.12.031 39.SriwilaijaroenN.MageshS.ImamuraA.AndoH.IshidaH.SakaiM.IshitsuboE.HoriT.MoriyaS.IshikawaT.et al.A novel potent and highly specific inhibitor against" exact="influenza" post="viral N1-N9 neuraminidases: Insight into neuraminidase-inhibitor interactionsJ. Med. Chem.2016594563457710.1021/acs.jmedchem.5b0186327095056"/>
 <result pre="neuraminidase-inhibitor interactionsJ. Med. Chem.2016594563457710.1021/acs.jmedchem.5b0186327095056 40.SriwilaijaroenN.SuzukiK.TakashitaE.HiramatsuH.KanieO.SuzukiY.6SLN-lipo PGA specifically catches (coats) human" exact="influenza" post="virus and synergizes neuraminidase-targeting drugs for human influenza therapeutic"/>
 <result pre="(coats) human influenza virus and synergizes neuraminidase-targeting drugs for human" exact="influenza" post="therapeutic potentialJ. Antimicrob. Chemother.2015702797280910.1093/jac/dkv19326169554 Figures, Scheme and Table Figure"/>
 <result pre="1 Synthesis of EdAP (5). Figure 3 Inhibition of the" exact="influenza" post="virus growth in the MDCKâ€&quot;SIAT1 cells by EdAP (5)."/>
 <result pre="MDCKâ€&quot;SIAT1 cells by EdAP (5). Upper panel: The number of" exact="influenza" post="virus-produced nucleoproteins (NPs) in cells decreased with an increase"/>
 <result pre="indicated. Lower panel: The reduction in the relative numbers of" exact="influenza" post="virus-produced NPs in cells was a function of EdAP"/>
</results>
